Since PVR is particularly expressed in lower-stage NB [34] and PVRL2 is associated with advanced tumour stage, rapid progression, and high malignancy [35], both receptors are worth consideration in the evaluation of further therapeutical approaches. The gene discussed is NECTIN2; the disease is neuroblastoma.